Pharmacy Market BUZZ

Market News, Products, Services, and Trends

Meet Leiters - Increasing Access to Mitosol® Through Partnership

Leiters, a trusted FDA-registered 503B outsourcing provider of high-quality ophthalmology and hospital-based services, has entered into a national sales and marketing agreement with Mobius Therapeutics™. Through the agreement, Leiters will be able to supply Mitosol®, the only FDA-approved formulation of mitomycin-c bearing an ophthalmic indication. The collaboration will ensure Leiters’ ophthalmic customers will have access to the high-quality medicines they need for their patients.

Mitosol® (mitomycin for solution) 0.2mg/vial is provided as part of a Kit for Ophthalmic Use. The kit contains a 0.2 mg vial of mitomycin-c along with accessories allowing for safe, convenient, and compliant acquisition, storage and handling of mitomycin-c.


Today's Posts


SPOTLIGHTS are brief introductions to companies, products, product features,
and services that could potentially benefit the pharmacy operations of RXinsider's readership.



To suggest a subject to be profiled in a SPOTLIGHT, please contact 
your RXinsider Account Manager or RXinsider's Marketing and Operations Manager, Samantha Roy.

This post is related to:

Admixture Compounding Services (503B Outsourcing Facilities)